On March 5, 2024, Ocular Therapeutix, Inc closed the transaction.
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
4.965 USD | +4.64% | -0.39% | +13.34% |
Apr. 18 | Health Care Flat on Rotation From Rate-Sensitive Sectors -- Health Care Roundup | DJ |
Apr. 18 | Ocular Therapeutix Reports Positive Topline Data in Diabetic Retinopathy Trial; Shares Fall | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+13.34% | 734M | |
+25.89% | 661B | |
+26.77% | 566B | |
-6.68% | 352B | |
+20.41% | 332B | |
+2.62% | 283B | |
+13.40% | 231B | |
+4.75% | 200B | |
-9.33% | 195B | |
-5.27% | 145B |
- Stock Market
- Equities
- OCUL Stock
- News Ocular Therapeutix, Inc.
- Ocular Therapeutix, Inc. announced that it has received $324.999962 million in funding from a group of investors